Major trial tests hopeful new treatment for debilitating spinal arthritis
NCT ID NCT07261644
Summary
This study is testing whether an experimental drug called 608 can reduce disease activity and improve symptoms in adults with active ankylosing spondylitis, a painful inflammatory spinal condition. It will compare 608 against a placebo in 500 participants over 60 weeks to see if it's effective and safe. The trial is for adults whose symptoms aren't adequately controlled by common anti-inflammatory medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 01
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.